NCT07271836 PLACE Trial: Preserving Long-Acting Contraception Through Education
| NCT ID | NCT07271836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pakistan Institute of Medical Sciences |
| Condition | Contraception |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 900 participants in total. It began in 2025-12-15 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study Overview Summary This randomized controlled trial will evaluate the effectiveness of structured counseling in improving the continuation rates of long-acting reversible contraception (LARC) among women in Islamabad, Pakistan, who present to family planning clinics for early removal of their contraception devices (copper-T IUD or Jadelle implant). The study, starting December 15, 2025, will recruit women from three federal government-approved clinics. The trial will randomly assign participants to either an intervention group, where they will receive culturally sensitive counseling to encourage continued use of LARC, or a control group, where contraception will be removed upon client request without counseling. The goal is to determine if structured counseling can increase the likelihood of women continuing their LARC method.
Eligibility Criteria
Inclusion Criteria: * Women presenting at the clinics exclusively for removal of a copper-T IUD or Jadelle subdermal implant within 2 years of use and within the first 2 months of the study. Exclusion Criteria: * Women not wishing to participate or unable to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07271836 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 49 Years, studying Contraception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07271836 currently recruiting?
Yes, NCT07271836 is actively recruiting participants. Contact the research team at ibrahim.k2000@gmail.com for enrollment information.
Where is the NCT07271836 trial being conducted?
This trial is being conducted at Islamabad, Pakistan, Islamabad, Pakistan, Islamabad, Pakistan.
Who is sponsoring the NCT07271836 clinical trial?
NCT07271836 is sponsored by Pakistan Institute of Medical Sciences. The trial plans to enroll 900 participants.